Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

Eirini Katodritou; Marie-Christine Kyrtsonis; Sosana Delimpasi; Despoina Kyriakou; Argiris Symeonidis; Emmanouil Spanoudakis; Georgios Vasilopoulos; Achilles Anagnostopoulos; Anna Kioumi; Panagiotis Zikos; Anthi Aktypi; Evangelos Briasoulis; Aikaterini Megalakaki; Panayiotis Repousis; Ioannis Adamopoulos; Dimitrios Gogos; Maria Kotsopoulou; Vassiliki Pappa; Eleni Papadaki; Despoina Fotiou; Eftychia Nikolaou; Evlambia Giannopoulou; Eleftheria Hatzimichael; Nikolaos Giannakoulas; Vassiliki Douka; Kyriaki Kokoviadou; Despoina Timotheatou; Evangelos Terpos

doi:10.1007/s00277-018-3404-8

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

Ann Hematol. 2018 Sep;97(9):1747. doi: 10.1007/s00277-018-3404-8.

Authors

Eirini Katodritou¹, Marie-Christine Kyrtsonis², Sosana Delimpasi³, Despoina Kyriakou⁴, Argiris Symeonidis⁵, Emmanouil Spanoudakis⁶, Georgios Vasilopoulos⁷, Achilles Anagnostopoulos⁸, Anna Kioumi⁹, Panagiotis Zikos¹⁰, Anthi Aktypi¹¹, Evangelos Briasoulis¹², Aikaterini Megalakaki¹³, Panayiotis Repousis¹³, Ioannis Adamopoulos¹⁴, Dimitrios Gogos¹⁵, Maria Kotsopoulou¹³, Vassiliki Pappa¹⁶, Eleni Papadaki¹⁷, Despoina Fotiou¹⁸, Eftychia Nikolaou², Evlambia Giannopoulou¹⁹, Eleftheria Hatzimichael¹², Nikolaos Giannakoulas⁷, Vassiliki Douka⁸, Kyriaki Kokoviadou⁹, Despoina Timotheatou¹⁸, Evangelos Terpos²⁰

Affiliations

¹ Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece. eirinikatodritou@gmail.com.
² First Department of Propaedeutic Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
³ Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece.
⁴ Department of Transfusion Medicine, School of Medicine, University of Thessaly, Larissa, Greece.
⁵ Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece.
⁶ Department of Hematology, Dimokrition University of Alexandroupolis, Alexandroupolis, Greece.
⁷ Department of Hematology, School of Medicine, University of Thessaly, Larissa, Greece.
⁸ Department of Hematology and Bone Marrow Transplantation Unit, George Papanicolaou Hospital, Thessaloniki, Greece.
⁹ Department of Hematology, Papageorgiou General Hospital, Thessaloniki, Greece.
¹⁰ Agios Andreas General Hospital, Patras, Greece.
¹¹ Olympion Clinic, Patras, Greece.
¹² Department of Hematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
¹³ Metaxa Cancer Hospital, Pireaus, Greece.
¹⁴ Kalamata General Hospital, Kalamata, Greece.
¹⁵ Mytilini General Hospital, Mytilene, Greece.
¹⁶ Attikon University Hospital, Athens, Greece.
¹⁷ University Hospital of Heraklion, Crete, Greece.
¹⁸ Medical Affairs, Genesis Pharma SA, Athens, Greece.
¹⁹ Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece.
²⁰ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Abstract

The original version of this article contained a mistake. The name of Eirini Katroditou should have been Eirini Katodritou. The original article has been corrected.

Publication types

Published Erratum